U.S. Botulinum Toxin Emerging Markets

Share this:
Published: 12 Feb 2003

The U.S. Botulinum toxin emerging markets report provides revenue forecasts, market shares, patient and procedure forecasts, market and technology trends, and existing and emerging applications. The market is segmented by product application, namely cosmetic and therapeutic. Within these segments, emphasis is placed on comparing botulinum toxin to other products in non-surgical cosmetic markets, and dystonia, spasticity and pain management markets. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.


Search Terms

40 sections of this document (indicated by ...) contain search terms


Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..